BWI: Sun Pharma to Announce Q3 Results on January 29, 2010

Press release from Business Wire India
Source: Sun Pharmaceuticals Industries Ltd
Tuesday, January 12, 2010 04:30 PM IST (11:00 AM GMT)
Editors: General: Consumer interest; Business: Banking & financial services, Financial Analyst, Healthcare, biotechnology & pharmaceutical, Stock exchanges; Healthcare
--------------------------------------------------
Sun Pharma to Announce Q3 Results on January 29, 2010


Mumbai, Maharashtra, India, Tuesday, January 12, 2010 -- (Business Wire India) -- On January 29 2010, Sun Pharma will announce results for the third quarter ending December 31st, 2009. These results will also be available on the Company website, www.sunpharma.com.

Earnings call (10.00 am IST, January 30, 2010)

The Company will conduct an hour long call at 10 am IST on January 30, 2010 where senior management will discuss the Company's performance and answer questions from participants. To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.

To view the Summary of Events, please click on the link given below:

Summary of Events

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, and orthopedics. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.

You have received this email as your address is part of our Investor Relations and Media Contacts list. All our Press Releases and Financial updates are sent to those on the list.

-- If you wish to be removed from this list or your address has been accidentally included here, then please let us know by a return email and we will remove it. All the others will continue to be on the mailing list.

-- If you wish to receive emails on some other email id, please send it to us.

-- If you think that somebody else from your organisation should be added to this list, then please ask him / her to send us an email and we will add.

-- If you are changing jobs, please send us your new email id. We would like to be in touch with you and keep you updated on happenings at Sun Pharma.

We would be happy to host one-on-one, group and telephone meetings for updates on the Company. If you wish to setup such a meeting, feel free to get in touch with us. In-person meetings can be at our office or elsewhere depending on mutual convenience.
For picture(s)/data to illustrate this release click below:

http://www.BusinessWireIndia.com/attachments/Summaryofevents.doc
Summaryofevents.doc


CONTACT DETAILS
Uday Baldota, Sun Pharmaceuticals Industries Ltd, +91 9867010529, uday.baldota@sunpharma.com
Mira Desai, Sun Pharmaceuticals Industries Ltd, +91 (22) 66455645, Ext 606/ +91 9821923797, mira.desai@sunpharma.com

KEYWORDS
CONSUMER, BANKING, Financial Analyst, HEALTHCARE, STOCK EXCHANGES, HEALTHCARE, SUNPHARMA.BO, SUNPHARMA .NS

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com